B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination-Reference-Cited by-同舟云学术

B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination

Published:2016-02-26 Issue:2 Volume:11 Page:e0149411
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kothur Kavitha,Wienholt Louise,Tantsis Esther M,Earl John,Bandodkar Sushil,Prelog Kristina,Tea Fiona,Ramanathan Sudarshini,Brilot Fabienne,Dale Russell C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis;A Carotenuto;Journal of medicinal chemistry,2001

2. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton;RC Dale;Neurology(R) neuroimmunology & neuroinflammation,2014

3. The spectrum of MOG autoantibody-associated demyelinating diseases;M Reindl;Nature reviews Neurology,2013

4. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease;F Brilot;Annals of neurology,2009

5. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype;J Kitley;Neurology,2012

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacological management of myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD): an update of the literature;Expert Review of Neurotherapeutics;2024-08-07

2. Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody–associated disease;Multiple Sclerosis Journal;2024-05-23

3. MOG antibody-associated optic neuritis;Eye;2024-05-23

4. Low T3 syndrome is associated with the severity of myelin oligodendrocyte glycoprotein antibody-associated disease exacerbation;Frontiers in Neuroscience;2024-05-21

5. Overview of Mechanisms Underlying Neuroimmune Diseases;Neuroimmune Diseases;2024